Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) COGS-to-Revenue : 0.24 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co COGS-to-Revenue?

Beijing Chunlizhengda Medical Instruments Co's Cost of Goods Sold for the three months ended in Dec. 2023 was HK$109.7 Mil. Its Revenue for the three months ended in Dec. 2023 was HK$455.4 Mil.

Beijing Chunlizhengda Medical Instruments Co's COGS to Revenue for the three months ended in Dec. 2023 was 0.24.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Beijing Chunlizhengda Medical Instruments Co's Gross Margin % for the three months ended in Dec. 2023 was 75.92%.

Beijing Chunlizhengda Medical Instruments Co COGS-to-Revenue Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co COGS-to-Revenue Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.31

0.27

0.23

0.24

0.28

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.20	-	0.33	0.24	0.26

Beijing Chunlizhengda Medical Instruments Co COGS-to-Revenue Calculation

Beijing Chunlizhengda Medical Instruments Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	363.83	/	1321.858
	=	0.28

Beijing Chunlizhengda Medical Instruments Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	109.667	/	455.415
	=	0.24

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Beijing Chunlizhengda Medical Instruments Co's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	109.667 / 455.415
	=	75.92 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Beijing Chunlizhengda Medical Instruments Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

688236:China

Address

No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN

Website

http://www.clzd.com

Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Citigroup Inc.	2502 Approved lending agent
Fidelity China Special Situations Plc	2101 Beneficial owner
Taiping Assets Management (hk) Company Limited	2102 Investment manager
Taiping Trustees Limited	2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines